Introducing Koala Prospector! Bringing Waterfall Enrichment to Reps

Learn More!
Kartos Therapeutics

Kartos Therapeutics

Kartos Therapeutics is a clinical stage biopharmaceutical company with a potential best-in-class MDM2 inhibitor (KRT-232) in clinical development, across a variety of TP53 wild-type hematological malignancies and solid tumors.

Last updated on

About Kartos Therapeutics

Founded

2018

Estimated Revenue

$1M-$10M

Employees

51-250

Category

Industry

Biotechnology

Location

City

Redwood City

State

California

Country

United States
Kartos Therapeutics

Kartos Therapeutics

Find your buyer within Kartos Therapeutics

Tech Stack (41)

search

Programming Languages And Frameworks

Devops And Development

Finance And Accounting

Customer Management

Computer Networks

Marketing

IT Security

Analytics and Tracking

Payment

Audio / Video Media

Content Management System

Advertising

Web Servers